1 / 20

When Using DOPPS Slides

When Using DOPPS Slides. DOPPS Slide Use Guidelines. Association of Mineral Metabolism Factors with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS). Introduction. DOPPS Background. Methods.

shauna
Télécharger la présentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. Association of Mineral Metabolism Factors with All-Cause and Cardiovascular Mortality in Hemodialysis Patients: the Japan Dialysis Outcomes and Practice Patterns Study (J-DOPPS)

  4. Introduction

  5. DOPPS Background

  6. Methods

  7. Table 1. Selected baseline sociodemographic variables, laboratory values, and comorbidity conditions for a prevalent cross-section of 3,973 HD patients* (1)

  8. Table 1. Selected baseline sociodemographic variables, laboratory values, and comorbidity conditions for a prevalent cross-section of 3,973 HD patients* (2)

  9. Table 2. Selected baseline % of pts meeting K/DOQI guideline targets for mineral metabolism measures for a prevalent cross-section of HD pts*

  10. Table 3. Associations between adjusted* relative risk of all-cause or cardiovascular mortality and mineral metabolism indicators

  11. Figure 1. Association between all-cause mortality and categorical measures of the mineral metabolism indicators: CalciumAlb (a), phosphorus (b)

  12. Figure 1. Association between all-cause mortality and categorical measures of the mineral metabolism indicators: calcium-phosphorus product (c) and iPTH(d)

  13. Figure 2. Association between cardiovascular mortality and categorical measures of the mineral metabolism indicators: CalciumAlb (a), phosphorus (b)

  14. Figure 2. Association between cardiovascular mortality and categorical measures of the mineral metabolism indicators: calcium-phosphorus product (c) and iPTH (d)

  15. Table 4. Use of specific therapies by laboratory guideline range*

  16. Results (1)

  17. Results (2)

  18. Conclusion

  19. Acknowledgements

More Related